This research paper proposes to analyse the impact of International Financial Reporting Standards (IFRS), on pharmaceutical companies. A graphical representation of its impact on the key performance indicators, after converging with IFRS, is presented in this paper. This study compared the financial ratios, prepared by using IGAAP and IFRS, on the date of transition, i.e. 1st April 2016, using Wilcoxon Signed Ranked Test. The study has exhibited significantly positive impact on most of the ratios under IFRS, when compared to those derived under Indian GAAP.
Volume 12 | 04-Special Issue